Hunan HuaTeng Pharmaceutical Co., Ltd.

company

About

Huateng Pharma offers high-end biological high-tech enterprise certification, chemical reagents & APIs.

  • 251 - 500

Details

Last Funding Type
Series A
Last Funding Money Raised
¥50M
Industries
Biopharma,Biotechnology,Chemical,Pharmaceutical
Founded date
Aug 1, 2013
Number Of Employee
251 - 500
Operating Status
Active

Hunan Huateng Pharmaceutical Co., Ltd is a company committed to research and development, production and sales of high-end PEG derivatives and products used across the pharmaceutical value chain including intermediates, excipients, APIs, and reagents. Huateng pharmaceuticals in Chinese, European and American countries have our own R & D and logistics center, the company has an excellent and efficient R & D and production and sales of a professional team. Fast for all global customers to provide professional, personalized and technical support of the one-stop service, can rapid and efficient delivery of products to the customers all around the world.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥50M
Hunan HuaTeng Pharmaceutical Co., Ltd. has raised a total of ¥50M in funding over 2 rounds. Their latest funding was raised on Sep 27, 2019 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 27, 2019 Series A ¥50M 3 Boyi Fund Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Hunan HuaTeng Pharmaceutical Co., Ltd. is funded by 3 investors. Boyi Fund and Dingteng Juzhi Investment are the most recent investors.
Investor Name Lead Investor Funding Round
Boyi Fund Yes Series A
Dingteng Juzhi Investment Series A
Zhudan Equity Investment Fund Series A